![]() Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. | ![]() Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. | ![]() Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. | |
Founding Date | Founding Date 2003 | Founding Date 2015 | Founding Date 2015 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Menlo Park, US HQ | Locations Cambridge, US HQ | Locations Stevenage, GB HQ Boston, US New York, US |
Employees | Employees 4337% increase | Employees 992% decrease | Employees 122 |
Financial | |||
Revenue (est.) | Revenue (est.) $106.7m (FY, 2021) | Revenue (est.) $22.9m (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods $30m (FY, 2021) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $76.7m (FY, 2021) | Gross profit N/A | Gross profit $8.9m (FY, 2022) |
Net income | Net income ($159.6m) (FY, 2021) | Net income ($37.2m) (FY, 2021) | Net income ($89m) (FY, 2022) |
Operating ⚠ | |||
Products | Products 2 (FY, 2016) | Products 11 (Q2, 2020) | Products N/A |
Trademarks | Trademarks 29 (FY, 2016) | Trademarks N/A | Trademarks 14 (May, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 102.9m | Total funding raised $ 168.5m | Total funding raised $ 289.3m |

Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View company
Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
View company